The Emirates Drug Corporation announced the adoption of the drug “Tolbrotinip” as the first oral medicine of its kind globally to treat multiple progressive secondary sclerosis.
source
The Emirates Drug Corporation announced the adoption of the drug “Tolbrotinip” as the first oral medicine of its kind globally to treat multiple progressive secondary sclerosis.
source